• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
    All News #Library
    Biotech

    Merck starts $1 billion Biologics Center in Delaware, US

    PRESS RELEASE

    Lilly pens $13M upfront oligonucleotide AI pact with Creyon Bio

    FIERCE BIOTECH

    Myosin Therapeutics gets $3M NIH grant for MT-110 trial

    PR NEWSWIRE

    Takeda to launch dengue vaccine in India with Biological E

    ECONOMICTIMES

    Pfizer ties PD-1 drug to 32% cancer risk reduction in phase 3

    FIERCE BIOTECH

    After FDA rejection, Regeneron scores EU nod for Lynozyfic

    FIERCE PHARMA

    Biohaven lands funding Oberland funding deal worth up to $600M

    FIERCE BIOTEC

    Merck KGaA in $3.9 B deal to buy US biotech firm SpringWorks

    REUTERS

    Dr Reddy`s to introduce Sanofi`s novel drug in India

    PRESS RELEASE

    Clasp Therapeutics Doses First Patient in Phase 1 Clinical Trial

    BUSINESSWIRE

    Alnylam Gets CHMP Backing for Vutrisiran in ATTR-CM

    BUSINESSWIRE

    enGene to Participate in Upcoming Investor Conferences

    BUSINESSWIRE

    VitriVax Gets CEPI Grant to Develop Single-Dose Rabies Vaccine

    BUSINESSWIRE

    Ankitva + BCG Shows 80% NMIBC Response at 36 Months

    BUSINESSWIRE

    Thermo Fisher Speeds Biologic Therapeutics Development

    BUSINESSWIRE

    Scribe, Prevail to Present In Vivo AAV Tech at ASGCT

    BUSINESSWIRE

    Crown Bioscience Launches 3D Bone Marrow Models at AACR

    BUSINESSWIRE

    Ankyra Therapeutics reveals Phase 1 data at 2025 AACR Meeting

    BUSINESSWIRE

    EpiBiologics Presents First Data on c-Met Bispecific Antibody

    BUSINESSWIRE

    CMS Grants Fresenius Kabi Permanent Q-Code for Otulfi®

    BUSINESSWIRE

    Edgewood Announces New Efficacy Data on BTX-A51 in Liposarcoma

    BUSINESSWIRE

    Mythic Therapeutics Shows MYTX-011 Efficacy at AACR Meeting

    BUSINESSWIRE

    Puma Biotech Presents Neratinib Data at AACR Meeting 2025

    BUSINESSWIRE

    Agenus presents BOT/BAL Neoadjuvant Pan-Cancer Data at AACR

    BUSINESSWIRE

    Encoded to Present CNS Gene Therapy Data at ASGCT Meeting

    BUSINESSWIRE

    Dyno Therapeutics to Present Breakthrough Data at ASGCT Meeting

    BUSINESSWIRE

    Obsidian Therapeutics to Present Preclinical Data at ASGCT Meeting

    BUSINESSWIRE

    Adicet Bio presents preclinical ADI-270 data at ASGCT Meeting

    BUSINESSWIRE

    Sangamo to Present Neurology Pipeline Advances at ASGCT

    BUSINESSWIRE

    STX-003 preclinical data for mRNA therapy in solid tumors

    BUSINESSWIRE

    Be Biopharma to Present at ASGCT 28th Annual Meeting

    BUSINESSWIRE

    Neurogene to Present on Rare Complication Reversal at ASGCT Meeting

    BUSINESSWIRE

    Affinia to Present BAG3, BBB AAV, and Tech at ASGCT 2025

    BUSINESSWIRE

    Chroma Bio to Present at ASGCT 2025 Annual Meeting

    BUSINESSWIRE

    CuraTeQ Biologics gets positive opinion for Dazublys biosimilar

    INDPHARMAPOST

    YolTech Releases Data on YOLT-101 Trial for Hypercholesterolemia

    PR NEWSWIRE

    Biocon Biologics Gets Positive CHMP Opinions for Denosumab

    PR NEWSWIRE

    Halozyme: Argen-X gets CHMP nod for Vygart in CIDP with enhanze

    PR NEWSWIRE

    Genprex Signs Exclusive License Agreement with NYU for Mesothelioma

    PR NEWSWIRE

    Galmed sign Term Sheet for Novel Semaglutide sublingual formulation

    PR NEWSWIRE

    GlycoNex Presents Preclinical Data on GNX1021 at AACR 2025

    PR NEWSWIRE

    Elpis Biopharmaceuticals to Present CAR-T Posters at AACR 2025

    PR NEWSWIRE

    AffyImmune to Present ICAM-1 CAR T Therapy AIC100 at AACR 2025

    PR NEWSWIRE

    PredxBio, Hamamatsu Photonics Partner for Spatial Biology Solution

    PR NEWSWIRE

    SK Life Science Labs` Research at AACR: p300-Selective Degraders

    PR NEWSWIRE

    Plexium to Present Selective Degrader Programs at AACR 2025

    PR NEWSWIRE

    Ferrer collaboration with Prilenia for Pridopidine deal

    BUSINESSWIRE

    US FDA requests Novavax for new COVID-19 trial

    REUTERS

    Pfizer`s Sasanlimab Combo Improves Survival in Bladder Cancer

    BUSINESSWIRE

    J&J’s TAR-200 monotherapy achieves 80% disease-free survival

    GLOBENEWSIRE

    Relmada Therapeutics To Present NDV-01 Data at AUA2025

    GLOBENEWSWIRE

    Abpro, Celltrion reveal data for ABP-102/CT-P72 at AACR 2025

    GLOBENEWSWIRE

    Precede Shows Blood Test Resolves Tumor Gene Expression

    GLOBENEWSWIRE

    Y-mAbs Presents CD38-SADA Pharmacokinetics at 2025 AACR Meeting

    GLOBENEWSWIRE

    Keytruda improves survival in head and neck Cancer

    BUSINESSWIRE

    OPTIMA II: UGN-102 Shows Two-Year Median Response

    BUSINESSWIRE

    UGN-102 Trials Show No QoL Impact in LG-IR-NMIBC Patients

    BUSINESSWIRE

    OLYMPUS Study: 4-Year Response With JELMYTO

    BUSINESSWIRE

    Nona Biosciences` Partner Pfizer Presents Data on TOP1i-Based ADC

    PR NEWSWIRE

    Innovent Presents Preclinical Data of Multiple Novel Molecules

    PR NEWSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.